Acute respiratory distress syndrome (ARDS) remains one of the most lethal complications of severe infections, sepsis, trauma, and viral pneumonia, but decades of research have yielded few targeted therapies that can improve patient outcomes.
A new review has been published Ferroptosis and oxidative stress suggests one reason for this treatment gap. Researchers may have focused on individual cell death pathways and overlooked the complex networks that connect them.
This review proposes a new perspective on the pathogenesis of ARDS, arguing that multiple forms of controlled cell death (RCD), including apoptosis, necroptosis, pyroptosis, ferroptosis, and other programmed death mechanisms, do not act independently. Instead, they communicate through extensive molecular crosstalk and collectively form a dynamic network that causes lung inflammation, alveolar damage, and respiratory failure.
Traditionally, research has investigated each cell death pathway individually, attempting to identify a single major mechanism responsible for acute lung injury. However, increasing genetic and biochemical evidence indicates that these pathways are highly interconnected. Blocking one form of cell death can activate another, and at the same time shared signaling molecules coordinate multiple cell death programs. This remarkable plasticity may help explain why therapies targeting individual pathways have shown limited clinical success.
The authors comprehensively summarize the molecular mechanisms underlying different regulated cell death modes and integrate emerging evidence showing how these pathways interact throughout ARDS development. Rather than viewing apoptosis, ferroptosis, pyroptosis, or necroptosis as isolated events, this review presents them as components of a coordinated biological network that amplifies tissue damage after infection or inflammatory injury.
Understanding this crosstalk could fundamentally change treatment strategies for ARDS. Rather than inhibiting a single cell death mechanism, future therapies may need to target common regulatory nodes common to multiple pathways to reduce excessive lung injury while maintaining essential immune defenses against pathogens. Such network-based approaches may also improve the effectiveness of combination therapies and support the development of precision medicine for critically ill patients.
In addition to highlighting current knowledge, this review identifies several important challenges for future research, including defining how different cell death pathways interact over time, identifying biomarkers that distinguish dominant cell death programs in individual patients, and discovering master regulators that can simultaneously coordinate multiple forms of regulated cell death.
As interest in ferroptosis and other programmed cell death mechanisms continues to expand across biomedical research, this review provides an integrated framework for understanding how cell death crosstalk contributes to ARDS. By shifting attention from individual pathways to interconnected regulatory networks, this study provides a new direction for treatment development for one of intensive care medicine’s most challenging diseases.
why is this important
- ARDS affects millions of patients worldwide and continues to have a high mortality rate despite advances in supportive care.
- In this review, we introduce a network-based view of regulated cell death and challenge traditional strategies that target a single death pathway.
- Understanding how apoptosis, pyroptosis, necroptosis, ferroptosis, and other programmed cell death pathways interact may facilitate the development of more effective treatments for ARDS and other inflammatory lung diseases.
sauce:
scientific exploration publishing
Reference magazines:
Zheng Y. Others. (2026) The role of multiple cell death modes in the pathogenesis of acute respiratory distress syndrome. Ferroptosis and oxidative stress. DOI: 10.70401/fos.2026.0024. https://www.sciexplor.com/fos/articles/fos.2026.0024
